I heard the call a few things from memory: - Gives them cash through end of 2018 - Don't look for another deal (at least in DMD) - May be an opportunity for drug in Becker's MD - Monotherapy is the current focus - Said had others interested but by comments seemed only SRPT made an offer. Said something to the effect of interest before but once got approval more interested. - Said have had partnership discussions on antibiotic
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.